StonvexLoading…
StonvexStonvexStonvexCore line items from BKH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.29B | $2.10B | $2.30B | $2.54B |
Operating Income | $537.50M | $503.10M | $472.70M | $455.20M |
Net Income | $291.60M | $273.10M | $262.20M | $258.40M |
EPS (Diluted) | $3.98 | $3.91 | $3.91 | $3.97 |
Total Assets | $10.87B | $10.02B | $9.62B | $9.62B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $182.80M | $16.10M | $86.60M | $21.40M |
Free Cash Flow OCF − CapEx | $-146.40M | $-24.90M | $388.80M | $-19.60M |
Shares Outstanding | 75.50M | 71.70M | 68.00M | 73.20M |